Over 18 years of experience in academic and biotech industry with increasing responsibility. Extensive experience in research, preclinical and clinical development including target discovery/validation, preclinical assay development, clinical assay deployment, pharmacodynamic and patient stratification biomarker development in oncology, inflammation and metabolic therapeutic areas. Manage a team of 20 scientists including 7 Ph.D. Specialties: Biomarker discovery and development, translational medicine, genomic and imaging platform
Executive Director at Gilead Sciences
MBA, Technology management